Ask The Doctors: August 2012

0
Pulmonary arterial hypertension (PAH) is a rare condition in which the small branches of the pulmonary arteries, known as arterioles, experience wall thickening and constriction. These pathological changes raise the pressure in the pulmonary arteries, as well as cause increased enlargement and strain on the right ventricle. People with PAH experience progressive shortness of breath, and nearly always need to use extra oxygen. Several classes of medication are used to treat PAH, including prostanoids such as iloprost, endothelin receptor antagonists like bosentan, and phosphodiesterase type 5 (PDE5) inhibitors. This last group of agents includes sildenafil, which is marketed under the trade name Revatio, but is identical to the medication Viagra, used to treat male erecticle dysfunction. Tadalafil (Adcirca) is the newest member of the PDE5 inhibitors, which has a long half-life in the circulation, and only needs to be taken once a day.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Heart Advisor

Get the next year of Heart Advisor for just $20. And access all of our online content - over 2,000 articles - free of charge.
Subscribe today and save 38%. It's like getting 5 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access

LEAVE A REPLY

Please enter your comment!
Please enter your name here